Community pharmacies and the provision of opioid substitution services for drug misusers: Changes in activity and attitudes of community pharmacists across England 1995-2005

Addiction

Volumn 102, Issue 11, 2007, Pages 1824-1830

  Sheridan, Janie ^a   Manning, Victoria ^b   Ridge, Gayle ^b   Mayet, Soraya ^b   Strang, John ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Buprenorphine; Community pharmacy; Methadone; Substance misuse; Supervised consumption

Indexed keywords

BUPRENORPHINE; METHADONE;

ARTICLE; COMMUNITY; DRUG MISUSE; FOLLOW UP; HEALTH SURVEY; HUMAN; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; QUESTIONNAIRE; STRUCTURED INTERVIEW; SUBSTITUTION THERAPY; TELEPHONE; UNITED KINGDOM;

ANALGESICS, OPIOID; ATTITUDE OF HEALTH PERSONNEL; BUPRENORPHINE; COMMUNITY PHARMACY SERVICES; ENGLAND; FEMALE; HEALTH PROMOTION; HUMANS; MALE; METHADONE; PHARMACIES; QUESTIONNAIRES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 35348838941     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2007.02016.x     Document Type: Article

References (25)

1. Sheridan J., Strang J., Barber N., Glanz A. Role of community pharmacies in relation to HIV prevention and drug misuse: findings from the 1995 national survey in England and Wales (see comment). BMJ 1996 313:272 4.
2. Glanz A., Byrne C., Jackson P. Role of community pharmacies in prevention of AIDS among injecting drug misusers: findings of a survey in England and Wales. BMJ 1989 299:1076 9.
3. Matheson C., Bond C. M., Hickey F. Prescribing and dispensing for drug misusers in primary care: current practice in Scotland. Fam Pract 1999 16:375 9.
4. Matheson C., Bond C. M., Pitcairn J. Community pharmacy services for drug misusers in Scotland: what difference does 5 years make? Addiction 2002 97:1405 11.
5. Sheridan J., Strang J., Taylor C., Barber N. HIV prevention and drug treatment services for drug misusers: a national study of community pharmacists' attitudes and their involvement in service specific training. Addiction 1997 92:1737 48.
6. Sheridan J., Lovell S., Turnbull P., Parsons J., Stimson G., Strang J. Pharmacy-based needle exchange (PBNX) schemes in south east England: a survey of service providers. Addiction 2000 95:1551 60.
7. Department of Health. The Task Force to Review Services for Drug Misusers - Report of an Independent Review of Drug Treatment Services in England. London:HMSO 1996.
8. Departments of Health. Drug Misuse and Dependence: Guidelines on Clinical Management. London:The Stationery Office 1999.
9. Sheridan J., Strang J. Reviewing the situation: pharmacists and drug misuse services in England and Wales. In:Sheridan J., Strang J., editors. Drug Misuse and Community Pharmacy. London:Taylor & Francis 2002, p. 37 46.
10. Walker M. Shared care for opiate substance misusers in Berkshire. Pharm J 2001 266:547 55.
11. Advisory Council on the Misuse of Drugs (ACMD). Reducing Drug Related Deaths: A Report of the Advisory Council on the Misuse of Drugs. London:The Stationery Office 2000.
12. Gruer L., Wilson P., Scott R., Elliot L., MacLeod J., Harden K., et al. General practitioner centred scheme for treatment of opiate dependent drug injectors in Glasgow. BMJ 1997 314:1730 5.
13. Best D., Campbell A. Summary of the NTA's National Prescribing Audit Research Briefing 19. London:National Treatment Agency for Substance Misuse 2006.
14. Strang J., Manning V., Mayet S., Ridge G., Best D., Sheridan J. Does opiate prescribing for addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005. Addiction 2007 102:761 70.
15. McBride A., Mali I., Atkinson R. Supervised administration of methadone by pharmacists. BMJ 1994 309:1234.
16. Morgan O., Griffiths C. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004. Int J Epidemiol 2006 35:1579 85.
17. Zador D., Mayet S., Strang J. Commentary: decline in methadone-related deaths probably relates to increased supervision of methadone in UK. Int J Epidemiol 2006 35:1586 7.
18. Department of Health. Models of Care for the Treatment of Drug Misusers: Promoting Quality, Efficiency and Effectiveness in Drug Misuse Treatment Services in England. London:National Treatment Agency for Substance Misuse 2002.
19. Department of Health. Improvement, Expansion and Reform: The Next 3 Years Priorities and Planning Framework 2003-2006. London:Department of Health 2002.
20. Sheridan J., Strang J. Late responders and nonresponders to a postal survey questionnaire: analysis of potential further response and nonresponse bias. Int J Pharm Pract 1998 6:170 5.
21. Winstock A. R., Sheridan J., Lovell S., Farrell M., Strang J. National survey of hepatitis testing and vaccination services provided by drug services in England and Wales. Eur J Clin Microbiol Infect Dis 2000 19:823 8.
22. Weitzel K., Goode J. Implementation of a pharmacy-based immunization program in a supermarket chain. J Am Pharm Assoc 2000 40:252 6.
23. Landis N. More pharmacists administering vaccines: training available through pharmaceutical associations, CDC. Am J Health Syst Pharm 1997 54:490 3.
24. Hind C., Peterkin G., Downie G., Michie C., Chisholm E. Successful provision of influenza vaccine from a community pharmacy in Aberdeen. Pharm J 2004 273:194 6.
25. Lacey H. Influenza vaccine is a logical progression from EHC provision. Pharm J 2002 269:710.